Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Ambry Genetics, DNAstack, Protea Biosciences, and More

NEW YORK (GenomeWeb) – Ambry Genetics announced this week that it has opened its AmbryShare data sharing program to the public. AmbryShare contains data on more than 1 million variants from 11,400 hereditary breast and ovarian cancer patients. It is comprised of de-identified aggregated allele frequency data that includes analysis of all genes in the human genome. The company is also soliciting collaborations with interested researchers for new AmbryShare exome projects on autism and prostate cancer. AmbyShare can be accessed here.

DNAstack announced this week that the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP) has invested in the company's cloud-based genomics software platform. DNAstack didn't specify the amount of the investment. The Toronto-based firm is developing its platform in partnership with the Global Alliance for Genomics & Health, which sets global standards for handling genomics and clinical information.

Protea Biosciences Group said this week that it has renewed its collaboration with California-based Protein Metrics to continue development of its advanced analytical software for Protea's molecular information services.

Exosome Diagnostics said this week that it has received ISO 15189 certification for its Munich laboratory, and can now process clinical samples in Asia, Europe, the Middle East, and Russia. Along with its CLIA-certified lab in Cambridge, Massachusetts, the Munich lab will help Exosome execute on its diagnostic strategy, the company said.

BGI Europe announced this week that its Copenhagen-based laboratory has received certification under ISO 15189:2013. BGI's Copenhagen lab provides a variety of next-generation sequencing and lab support services including whole-genome sequencing, clinical exome sequencing, transcriptome sequencing, DNA extraction, and sequencing of constructed libraries.

Castle Biosciences this week was awarded accreditation from the College of American Pathologists for its new laboratory facility in Phoenix, Arizona. The 10,000-square-foot laboratory is also CLIA certified.

In Brief This Week is a selection of news items that may be of interest to our readers but had not previously appeared on the GenomeWeb site.